BOSTON SCIENTIFIC CORPORATION Deferred Revenue Recognized
BOSTON SCIENTIFIC CORPORATION (BSX) reported Deferred Revenue Recognized of $264.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-02-17
- BOSTON SCIENTIFIC CORPORATION contract with customer, liability, revenue recognized for the quarter ending 2025-09-30 was $65.00M, a 14.04% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION contract with customer, liability, revenue recognized for the quarter ending 2025-06-30 was $68.00M, a 15.25% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was $68.00M, a 9.68% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION contract with customer, liability, revenue recognized for the quarter ending 2024-09-30 was $57.00M, a 9.62% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION contract with customer, liability, revenue recognized for fiscal 2025 was $264.00M, a 14.29% increase from fiscal 2024.
- BOSTON SCIENTIFIC CORPORATION contract with customer, liability, revenue recognized for fiscal 2024 was $231.00M, a 8.45% increase from fiscal 2023.
- BOSTON SCIENTIFIC CORPORATION contract with customer, liability, revenue recognized for fiscal 2023 was $213.00M, a 36.54% increase from fiscal 2022.
- BOSTON SCIENTIFIC CORPORATION contract with customer, liability, revenue recognized for fiscal 2022 was $156.00M, a 1.89% decline from fiscal 2021.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 6 month as first filed | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 9 month as first filed | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|---|---|
| 2025-12-31 | $264.00M 10-K · filed 2026-02-17 | |||||
| 2025-09-30 | $65.00M 10-Q · filed 2025-11-03 | $201.00M 10-Q · filed 2025-11-03 | ||||
| 2025-06-30 | $68.00M 10-Q · filed 2025-08-01 | $136.00M 10-Q · filed 2025-08-01 | ||||
| 2025-03-31 | $68.00M 10-Q · filed 2025-05-01 | |||||
| 2024-12-31 | $231.00M 10-K · filed 2025-02-18 | |||||
| 2024-09-30 | $57.00M 10-Q · filed 2024-11-01 | $177.00M 10-Q · filed 2024-11-01 | ||||
| 2024-06-30 | $59.00M 10-Q · filed 2024-08-01 | $120.00M 10-Q · filed 2024-08-01 | ||||
| 2024-03-31 | $62.00M 10-Q · filed 2024-05-01 | |||||
| 2023-12-31 | $213.00M 10-K · filed 2024-02-20 | |||||
| 2023-09-30 | $52.00M 10-Q · filed 2023-11-01 | $164.00M 10-Q · filed 2023-11-01 | ||||
| 2023-06-30 | $35.00M 10-Q · filed 2023-08-03 | |||||
| 2023-03-31 | $42.00M 10-Q · filed 2023-05-04 | |||||
| 2022-12-31 | $156.00M 10-K · filed 2023-02-23 | |||||
| 2022-09-30 | $39.00M 10-Q · filed 2022-11-03 | |||||
| 2022-06-30 | $35.00M 10-Q · filed 2022-08-04 | |||||
| 2022-03-31 | $42.00M 10-Q · filed 2022-05-05 | |||||
| 2021-12-31 | $159.00M 10-K · filed 2022-02-23 | |||||
| 2021-09-30 | $39.00M 10-Q · filed 2021-11-04 | $116.00M 10-Q · filed 2022-11-03 | $113.00M 10-Q · filed 2021-11-04 | |||
| 2021-06-30 | $38.00M 10-Q · filed 2021-08-06 | $76.00M 10-Q · filed 2022-08-04 | $74.00M 10-Q · filed 2021-08-06 | |||
| 2021-03-31 | $36.00M 10-Q · filed 2022-05-05 | |||||
| 2020-12-31 | $135.00M 10-K · filed 2021-02-23 | |||||
| 2020-09-30 | $28.00M 10-Q · filed 2020-11-05 | $84.00M 10-Q · filed 2020-11-05 | ||||
| 2020-06-30 | $31.00M 10-Q · filed 2020-08-05 | $66.00M 10-Q · filed 2020-08-05 | ||||
| 2020-03-31 | $35.00M 10-Q · filed 2020-05-06 | |||||
| 2019-12-31 | $143.00M 10-K · filed 2020-02-25 | |||||
| 2019-09-30 | $35.00M 10-Q · filed 2019-11-05 | $107.00M 10-Q · filed 2019-11-05 | ||||
| 2019-06-30 | $36.00M 10-Q · filed 2019-07-30 | $72.00M 10-Q · filed 2019-07-30 | ||||
| 2019-03-31 | $36.00M 10-Q · filed 2019-04-29 | |||||
| 2018-12-31 | $117.00M 10-K · filed 2019-02-19 | |||||
| 2018-09-30 | $27.00M 10-Q · filed 2018-10-29 | $80.00M 10-Q · filed 2018-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |